News
Respiri Limited (ASX: RSH) are an Australian owned company with smart tools to empower people with asthma and improve outcomes.
Backed by over twenty years of research by respiratory specialists, and with first-move advantage, Respiri offers an over-the-counter monitoring solution that will help people manage asthma in ways that have never been available before.
KEY PEOPLE
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: CBA makes bank from rising rates, then issues a warning about mortgage arrears
News
CLOSING BELL: Late rally sees the ASX almost emerge from day-long lurk in the bog
Health & Biotech
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines
News
CLOSING BELL: Mega gold merger outweighs bankers’ ex-div dive, leaving the ASX up 0.1%
News
Weekly Small Caps and IPO Wrap: Data, data everywhere, but nary a spot to think
Health & Biotech
Check Up: Moderna posts crazy cancer vaccine results, says melanoma recurrence down by almost half
News
Market Highlights: SBF finds $375m down the back of mum and dad’s couch, and 5 ASX small caps to watch today
Health & Biotech
ASX Health Stocks: Respiri expands footprints to New Mexico; Bionomics has a new CEO
Health & Biotech
ASX Health Stocks: FDA greenlights Anteris study, Respiri selected in Arkansas
News
Market Highlights: ASX to end winning streak, and 5 small caps to watch on Monday
Health & Biotech
ASX Health Stocks: Argenica’s Phase 1 trial takes crucial step forward after drug safety confirmed
News
Market Highlights: Wall St dips on hawkish Fed, and 5 ASX small caps to watch on Friday
Health & Biotech
ASX Biotech Stocks: Medibank says nope to paying ransom for data theft
Health & Biotech
ASX Health Stocks: Respiri lifts 14pc after giving update on US market
Health & Biotech
ASX Health Stocks: US market brings home the bacon for HeraMED and Respiri
Health & Biotech